✦ LIBER ✦

Potential predictors of response to immunomodulation in patients with myasthenia gravis

✍ Scribed by Li, Hai-Feng; Liu, Tao; Hong, Yu; Zhang, Hong-Liang

Book ID: 118764850
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 61 KB
Volume: 46
Category: Article
ISSN: 0148-639X
DOI: 10.1002/mus.23495

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictors of response to immunomodulati

Predictors of response to immunomodulation in patients with myasthenia gravis

✍ Hans D. Katzberg; Carolina Barnett; Vera Bril 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 774 KB

123. Predictors of response to immunomod

123. Predictors of response to immunomodulation in myasthenia gravis

✍ H.D. Katzberg; C. Barnett; D. Barth; V. Bril 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 35 KB

Response to thymectomy in Chinese patien

Response to thymectomy in Chinese patients with myasthenia gravis

✍ Richard Kay; Simon Lam; K.S. Wong; Angela Wang; Jonathan Ho 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 307 KB

Response to thymectomy in South Indian p

Response to thymectomy in South Indian patients with myasthenia gravis

✍ S. K. Narayan; C. Sarada; K. Radhakrishnan; M.D. Nair; C. C. Kartha; K. S. Neela 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 409 KB

Cellular response to human acetylcholine

Cellular response to human acetylcholine receptor in patients with myasthenia gravis

✍ Daniel P. McQuillen; Susan M. Koethe; Michael P. McQuillen 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 266 KB

Response of myasthenia gravis to rituxim

Response of myasthenia gravis to rituximab in a patient with non-Hodgkin lymphoma

✍ Ajeet Gajra; Neerja Vajpayee; Sara J. Grethlein 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 43 KB 👁 2 views

## Abstract Myasthenia gravis is a B‐cell‐mediated autoimmune neuromuscular disorder characterized by weakness and fatigability of skeletal muscles. The underlying defect is an autoantibody‐mediated attack on the acetylcholine receptors (AchRs) at the neuromuscular junction. Rituximab is a genetica